Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences.

Paxlovid (nirmatrelvir plus ritonavir) is a new oral antiviral therapeutic for the treatment and post-exposure prophylaxis of COVID-19. Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease, while ritonavir is used as a CYP3A inhibitor in low doses to slow the metabolism of nirmatrelvir, thus enhancing their therapeutic effect. The isoenzyme CYP3A4 is responsible for at least part of the oxidative metabolism of approximately 60% of available medications and ritonavir is therefore a significant source of drug interactions. We describe here the drugs that are contraindicated or should be used with or without precautions when Paxlovid (nirmaltrevir plus ritonavir) should be administered according to each fact sheet in force at the Spanish Agency for Medicines and Health Products.

Mastitis granulomatosa idiopática complicada con absceso de mama producido por Gordonia sputi, caso clínico / Idiopathic granulomatous mastitis complicated with a breast abscess caused by Gornodia sputi, a case report

La mastitis granulomatosa idiopática es una entidad rara, benigna y crónica de causa desconocida que afecta a la mama. Es un diagnóstico de exclusión. Se deben descartar, entre otras etiologías, la tuberculosis, las infecciones, la sarcoidosis y otras enfermedades autoinmunes, como la arteritis de células gigantes. Los principales retos que plantea esta entidad son su diagnóstico diferencial con enfermedad maligna y su tratamiento. La afectación mamaria es anecdótica y ha sido solo reportada en relación con prótesis mamarias. Presentamos el caso de una paciente diagnosticada de mastitis granulomatosa idiopática complicada con un absceso de mama por Gordonia sputi.

Idiopathic granulomatous mastitis is a rare, benign, chronic entity of unknown cause affecting the breast. It is a diagnosis of exclusion. Among other aetiologies, tuberculosis, infections, sarcoidosis, and other autoimmune diseases such as giant cell arteritis must be ruled out. The main challenges posed by this entity are its differential diagnosis with malignant pathology and its treatment.Gordonia spp. are a group of emerging pathogens that are mainly associated with infections associated with medical devices, mainly catheters. Breast involvement is anecdotal and has only been reported in relation to breast prostheses.We present the case of a patient diagnosed with idiopathic granulomatous mastitis complicated with a breast abscess due to Gordonia sputi.

Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain.

BACKGROUND: Diabetes is one of the underlying risk factors for developing community-acquired pneumonia (CAP). The high prevalence of diabetes among population and the rising incidence of this illness, converts it as an important disease to better control and manage, to prevent its secondary consequences as CAP. The objective of this research is to describe the characteristics of the patients with diabetes and the differences with the no diabetes who have had an episode of CAP in the context of the primary care field. METHODS: A retrospective, observational study in adult patients (> 18 years-old) who suffer from CAP and attended at primary care in Spain between 2009 and 2013 was developed using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). We carried out a descriptive analysis of the first episodes of CAP, in patients with or without diabetes as comorbidity. Other morbidity (CVA, Anaemia, Arthritis, Asthma, Heart disease, Dementia, Depression, Dysphagia, Multiple sclerosis, Epilepsy, COPD, Liver disease, Arthrosis, Parkinson's disease, Kidney disease, HIV) and life-style factors were also included in the study. RESULTS: A total of 51,185 patients were included in the study as they suffer from the first episode of CAP. Of these, 8012 had diabetes as comorbidity. There were differences between sex and age in patients with diabetes. Patients without diabetes were younger, and had less comorbidities including those related to lifestyles such as smoking, alcoholism, social and dental problems than patients with diabetes. CONCLUSIONS: Patients who developed an episode of CAP with diabetes have more risk factors which could be reduced with an appropriate intervention, including vaccination to prevent successive CAP episodes and hospitalization. The burden of associated factors in these patients can produce an accumulation of risk. Health care professional should know this for treating and control these patients in order to avoid complications. Diabetes and those other risk factors associated could be reduced with an appropriate intervention, including vaccination to prevent the first and successive CAP episodes and the subsequent hospitalization in severe cases.

Utilidad de la técnica de Gram en exudados uretrales en la consulta de atención primaria / Usefulness of the Gram stain in urethral exudates in the Primary Care Unit

No disponible

[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update]. / Consenso sobre la vacunación anti-neumocócica en el adulto por riesgo de edad y patología de base. Actualización 2017.

Invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP) represent an important health problem among aging adults and those with certain underlying pathologies and some diseases, especially immunosuppressed and some immunocompetent subjects, who are more susceptible to infections and present greater severity and worse evolution. Among the strategies to prevent IPD and PP, vaccination has its place, although vaccination coverage in this group is lower than desirable. Nowadays, there are 2 vaccines available for adults. Polysacharide vaccine (PPV23), used in patients aged 2 and older since decades ago, includes a greater number of serotypes (23), but it does not generate immune memory, antibody levels decrease with time, causes an immune tolerance phenomenon, and have no effect on nasopharyngeal colonization. PCV13 can be used from children 6 weeks of age to elderly and generates an immune response more powerful than PPV23 against most of the 13 serotypes included in it. In the year 2013 the 16 most directly related to groups of risk of presenting IPD publised a series of vaccine recommendations based on scientific evidence regarding anti-pneumococcal vaccination in adults with underlying pathologies and special conditions. A commitment was made about updating it if new scientific evidence became available. We present an exhaustive revised document focusing mainly in recommendation by age in which some more Scientific Societies have been involved.

Resumen del Consenso sobre la Vacunación Antineumocócica en el Adulto por Riesgo de Edad y Patología de Base. Actualización 2017 / No disponible

En el año 2013 algunas de las Sociedades Científicas más directamente relacionadas con los grupos de riesgo para padecer enfermedad neumocócica publicamos un documento de Consenso con una serie de recomendaciones basadas en las evidencias científicas respecto a la vacunación antineumocócica en el adulto con condiciones especiales y patología de base. Se estableció un compromiso de discusión y actualización ante la aparición de nuevas evidencias. Fruto de este trabajo de revisión, en abril de 2017 se ha publicado una actualización del anterior documento junto a 4 nuevas Sociedades Científicas donde destaca, entre otras novedades, la recomendación de vacunación por criterio de edad. Se resumen algunas de las principales novedades que presenta la actualización del documento de Consenso

In the year 2013 some of the most directly related to groups of risk of presenting IPD Scientific Societies published a series of vaccine recommendations based on scientific evidence regarding anti-pneumococcal vaccination in adults with underlying pathologies and special conditions. A commitment was made about updating it if new scientific evidence became available. In april 2017 an exhaustive revision over the previous document was published focusing mainly in recommendation by age. We review some of the main changes in the new Consensus document

Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).

BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain. METHODS: Retrospective observational study in adults (>18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). RESULTS: Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7 % males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3 %, which increased with age, doubling the risk in males by the age of 75 (females 20 % vs males 40 %). From 55 years of age, at least one risk factor was identified in 85.7 % of cases: one risk factor (23.8 %), two risk factors (23.4 %), three or more risk factors (38.5 %). Major risk factors were: metabolic disease (27.4 %), cardiovascular disease (17.8 %) and diabetes (15.5 %). CONCLUSIONS: The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes.

[Mortality and prognostic factors in patients admitted with community-acquired bacteremia]. / Mortalidad y factores pronósticos en pacientes hospitalizados por bacteriemia adquirida en la comunidad.

BACKGROUND: Community-acquired bacteremia is a frequently clinical problem and is associated with a high mortality. The Pitt bacteremia score that is calculated using body temperature, mental status, and some respiratory and circulatory features is an useful tool in order to know the prognosis of patients with bacteremia. Objectives were to know microbial etiology of bacteremia in our community, percentage of patients that received an inadequate empiric antibiotic treatment and independent prognostic factors associated with mortality, including Pitt bacteremia score. METHOD: Observational study of a cohort of patients over 18 years admitted at a tertiary hospital due to an infection with a community-acquired bacteremia. Twenty-eight cases were rejected because possible blood culture contamination. RESULTS: Seventy-five patients were included, the mean age was 68.6 +/- 18.2 years, 38 women (51%). Mortality rate was 23% [IC95% 13.8-33.8]. More frequent bacteria isolated were Escherichia coli, Staphylococcus aureus, coagulase negative staphylococci, Pseudomonas aeruginosa, Streptococcus viridans, enterococci and Klebsiella spp. Mortality in patients treated with an inadequate antibiotic therapy (18%, 3 patients) was not lower than in adequately treated patients (24%, 14 patients, p = 0.42). Independent prognostic factors related to mortality were serum albumin concentration, OR = 5.17 (IC 95% 1.45-16.7) for every downing step of 1 g/dl, the Pitt bacteremia score OR = 1.50 (IC 95% 1.01-2.24) for every unit increase, and a high score at McCabe and Jackson classification OR = 5.08 ( IC 95% 1.43-16.7). CONCLUSIONS: An inadequate empiric antibiotic therapy was not associated with a worse vital prognosis. Independent prognostic factors related to mortality were serum albumin concentration, the Pitt bacteremia score, and the McCabe and Jackson classification.

Mortalidad y factores pronósticos en pacientes hospitalizados por bacteriemia adquirida en la comunidad / Mortality and prognostic factors in patients admitted with community-acquired bacteremia

Introducción: La bacteriemia adquirida en la comunidad es un problema frecuente y de elevada mortalidad. El índice de Pitt, calculado en base a la temperatura, el estado mental, y las funciones circulatoria y respiratoria del paciente es una herramienta útil para conocer el pronóstico de pacientes con bacteriemia. Los objetivos fueron conocer la etiología de las bacteriemias adquiridas en la comunidad en nuestro entorno, el porcentaje de pacientes con tratamiento empírico incorrecto, y determinar la mortalidad y los factores independientes asociados con el fallecimiento del paciente, incluido el índice de Pitt. Método: Estudio observacional de una cohorte de pacientes mayores de 18 años ingresados en un hospital terciario por una infección adquirida en la comunidad con bacteriemia. Veintiocho casos fueron desestimados por considerar el aislamiento bacteriano como contaminante. Resultados: Se incluyeron 75 enfermos con un promedio de edad de 68,6 ± 18,2 años, 38 mujeres (51%). La mortalidad fue del 23% [IC95% 13,8 – 33,8]. Las bacterias más frecuentemente aisladas en los hemocultivos fueron Escherichia coli, Staphylococcus aureus, estafilococos coagulasa negativo, Pseudomonas aeruginosa, Streptococcus viridans, enterococos y Klebsiella spp. La mortalidad de los pacientes con un tratamiento antibiótico empírico inadecuado (18%, 3 pacientes) no fue inferior a los que recibieron un tratamiento empírico correcto en urgencias (24 %, 14 pacientes, p = 0,42). Los factores independientes pronósticos de mortalidad, fueron la baja concentración plasmática de albúmina, OR = 5,17 (IC 95% 1,45-16,7) para cada descenso de 1 g/dl, el elevado índice de Pitt OR = 1,50 (IC 95% 1,01-2,24) para cada aumento de una unidad, y la elevada gravedad de la enfermedad de base medida por el índice de McCabe y Jackson OR = 5,08 ( IC 95% 1,43-16,7). Conclusiones: El tratamiento antibiótico empírico incorrecto no influyó en la mortalidad de pacientes con bacteriemia comunitaria. Los factores pronósticos de mortalidad fueron la concentración plasmática de albúmina, el índice de Pitt y la gravedad de la enfermedad de base medida por el índice de McCabe y Jackson

Background: Community-acquired bacteremia is a frequently clinical problem and is associated with a high mortality. The Pitt bacteremia score that is calculated using body temperature, mental status, and some respiratory and circulatory features is an useful tool in order to know the prognosis of partients with bacteremia. Objetives were to know microbial etiology of bacteremia in our community, percentage of patients that received an inadequate empiric antibiotic treatment and indepedent prognostic factors associated with mortality, including Pitt bacteremia score. Method: Observational study of a cohort of patients over 18 years admitted at a tertiary hospital due to an infection with a community-acquired bacteremia. Twenty-eight cases were rejected because possible blood culture contamination. Results: Seventy-five patients were included, the mean age was 68.6 ± 18.2 years, 38 women (51%). Mortality rate was 23% [IC95% 13.8 – 33.8]. More frequent bacteria isolated were Escherichia coli, Staphylococcus aureus, coagulase negative staphilococci, Pseudomonas aeruginosa, Streptococcus viridans, enterococci and Klebsiella spp. Mortality in patients treated with an inadequate antibiotic therapy (18%, 3 patients) was not lower than in adequately treated patients (24%, 14 patients, p=0.42). Indepedent prognostic factors related to mortality were serum albumin concentration, OR=5.17 (IC 95% 1.45-16.7) for every downing step of 1 g/dl, the Pitt bacteremia score OR=1.50 (IC 95% 1.01-2.24) for every unit increase, and a high score at McCabe and Jackson classification OR=5.08 ( IC 95% 1.43-16.7) Conclusions: An inadequate empiric antibiotic therapy was not associated with a worse vital prognosis. Indepedent prognostic factors related to mortality were serum albumin concentration, the Pitt bacteremia score, and the McCabe and Jackson classification